Vivos Therapeutics Inc Q2 2025 Earnings Call Transcript - Thomson StreetEvents

Vivos Therapeutics Inc Q2 2025 Earnings Call Transcript

Vivos Therapeutics Inc Q2 2025 Earnings Call Transcript - Thomson StreetEvents
Vivos Therapeutics Inc Q2 2025 Earnings Call Transcript
Published Aug 19, 2025
11 pages (6178 words) — Published Aug 19, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of VVOS.OQ earnings conference call or presentation 19-Aug-25 9:00pm GMT

  
Brief Excerpt:

...Operator Good day, everyone, and welcome to the Vivos second quarter 2025 conference call. (Operator Instructions) This conference call is being recorded, and a replay of today's call will be available on the investor relations section of Vivos website and will remain posted there for the next 30 days. I will now hand the call over to Mr. Brad Amman, Chief Financial Officer, for introductions and the reading of the safe harbor statement. Please go ahead. Bradford Amman ...

  
Report Type:

Transcript

Source:
Company:
Vivos Therapeutics Inc
Ticker
VVOS.OQ
Time
9:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Robert Sassoon - Water Tower Research LLC - Analyst : You talked about the SO teams. How do you go about recruiting those professionals? And is there sort of a time line in your mind as to how long you can put together each team?


Question: Robert Sassoon - Water Tower Research LLC - Analyst : Okay, good. You mentioned that you're always looking for opportunities for acquisition, but are you prioritizing bedding down the SCN acquisition? Or are you going to be opportunistic and look at and acquire or partner with other sleep centers?


Question: Robert Sassoon - Water Tower Research LLC - Analyst : Yeah. Just following up on the SOT question. Have you actually worked with SOTs before? Has there been any issues you would consider?


Question: Robert Sassoon - Water Tower Research LLC - Analyst : Right. Just another question on the balance sheet. You've taken on a bit of debt now, fairly expensive debt, I think. Are there any plans to refinance that? And/or maybe you can give us a run-through on the financial strategy going forward.


Question: Robert Sassoon - Water Tower Research LLC - Analyst : Yeah. And as a final question for me, is there a sort of a level of revenues you need? At what point you think it could be cash breakeven? At what point of revenue?


Question: Robert Sassoon - Water Tower Research LLC - Analyst : Yeah, I mean, I just wondered. It's probably you'll have a better idea as the next few quarters go on. So I guess it's really dependent on how quickly you recruit.

Table Of Contents

Vivos Therapeutics Inc To Participate in Online Fireside Chat with Water Tower Research Transcript – 2025-12-16 – US$ 54.00 – Edited Transcript of VVOS.OQ corporate analyst meeting</ 16-Dec-25 4:00pm GMT

Vivos Therapeutics Inc Q3 2025 Earnings Call Transcript – 2025-11-19 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 19-Nov-25 10:00pm GMT

Vivos Therapeutics Inc Annual Shareholders Meeting Transcript – 2025-11-04 – US$ 54.00 – Edited Transcript of VVOS.OQ shareholder or annual meeting 4-Nov-25 5:00pm GMT

Vivos Therapeutics Inc Q1 2025 Earnings Call Transcript – 2025-05-15 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 15-May-25 9:00pm GMT

Vivos Therapeutics Inc Q4 2024 Earnings Call Transcript – 2025-03-31 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 31-Mar-25 9:00pm GMT

Vivos Therapeutics Inc To Participate in Fireside Chat with Water Tower Research Transcript – 2025-02-18 – US$ 54.00 – Edited Transcript of VVOS.OQ corporate analyst meeting</ 18-Feb-25 5:00pm GMT

Vivos Therapeutics Inc Annual Shareholders Meeting Transcript – 2024-11-26 – US$ 54.00 – Edited Transcript of VVOS.OQ shareholder or annual meeting 26-Nov-24 5:00pm GMT

Vivos Therapeutics Inc Q3 2024 Earnings Call Transcript – 2024-11-14 – US$ 54.00 – Edited Transcript of VVOS.OQ earnings conference call or presentation 14-Nov-24 10:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Vivos Therapeutics Inc Q2 2025 Earnings Call Transcript" Aug 19, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2025-Vivos-Therapeutics-Inc-Earnings-Call-T16482618>
  
APA:
Thomson StreetEvents. (2025). Vivos Therapeutics Inc Q2 2025 Earnings Call Transcript Aug 19, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2025-Vivos-Therapeutics-Inc-Earnings-Call-T16482618>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.